Andreas Kiesbye Øvlisen

INTRODUCTION Infertility is a well-known late effect of cancer treatment, including treatment of acute leukaemia (AL).1-6 The growing number of long-term cancer survivors highlights the importance of addressing these late effects.7, 8 Furthermore, improved survival of patients with AL9, 10 and higher age for first-time parenthood in the Western world11 may cause more patients to have unfulfilled family plans when faced with an AL diagnosis.

INTRODUCTION Classical Hodgkin lymphoma (cHL) is a B-cell neoplasm characterized by a bimodal age distribution with first incidence peak at the age of 20–30 years and again after the age of 50 years.1, 2 Survival for cHL patients has improved substantially in the past decades, and contemporary intensive first-line treatments cure ≥80% with advanced-stage disease.3, 4 Relapses after first complete metabolic remission are frequent, and residual life expectancy is close to that of the background...

Editorial Tarec Christoffer El-Galaly MD, DMSci, Corresponding Author tarec.galaly@gmail.com orcid.org/0000-0002-4406-380X Department of Hematology, Aalborg University Hospital, Aalborg, Denmark Department of Clinical Medicine, Aalborg University, Aalborg, Denmark Corresponding Author: Tarec Christoffer El-Galaly, MD, DMSci, Department of Hematology, Aalborg University Hospital, Moelleparkvej 4, Dk-9000 Aalborg, Denmark (tarec.galaly@gmail.com).